secwatch.observer — SEC 8-K summary
======================================

Issuer:     CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL)
CIK:        0001100682
Form:       8-K
Filed at:   2021-11-03T23:59:59+00:00
Accession:  0001157523-21-001314
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Charles River Q3 revenue $895.9M (+20.5% YoY); non-GAAP EPS $2.70; updates 2021 guidance
--------------------------------------------------------------------------------

- Revenue $895.9M, +20.5% YoY; organic growth 13.6% with contributions from all three segments.
- GAAP EPS $2.01 (-1.0% YoY) includes $0.15 loss from venture investments; non-GAAP EPS $2.70 (+15.9%).
- RMS segment revenue $171.3M (+12.7% YoY); DSA $531.8M (+15.3%); Manufacturing $192.9M (+48.1%).
- 2021 guidance: reported revenue growth 19.5%-20.5% (from 20.5%-22.5%); GAAP EPS raised to $7.05-$7.15; non-GAAP EPS $10.20-$10.30.
- Completed divestitures of RMS Japan and CDMO Sweden on Oct 12; reduces Q4 revenue ~$20M and non-GAAP EPS <$0.10.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1100682/000115752321001314/0001157523-21-001314-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1100682/000115752321001314/a52520056.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-001314

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer